XNYSNEUE
Market cap59mUSD
Jan 08, Last price
7.42USD
1D
0.27%
1Q
32.48%
IPO
-99.46%
Name
Bright Health Group Inc
Chart & Performance
Profile
Bright Health Group, Inc., a healthcare company, provides health insurance policies in the United States. It operates in two segments, NeueHealth and Bright HealthCare. The NeueHealth segment delivers virtual and in-person clinical care services to patients under contracts through its owned and affiliated primary care clinics. As of December 31, 2021, it worked with approximately 260,000 care provider partners; and operated 180 managed and affiliated risk-bearing clinics within its integrated care delivery system, which included embedded pharmacy, laboratory, radiology, and population health focused specialty services. The Bright HealthCare segment offers commercial and medicare health plan products to consumers in 14 states and 99 markets. The company was formerly known as Bright Health Inc. and changed its name to Bright Health Group, Inc. in February 2021. Bright Health Group, Inc. was incorporated in 2015 and is headquartered in Minneapolis, Minnesota.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
Income | ||||||
Revenues | 1,160,802 54.53% | 751,163 -50.35% | ||||
Cost of revenue | 1,255,739 | 1,060,422 | ||||
Unusual Expense (Income) | ||||||
NOPBT | (94,937) | (309,259) | ||||
NOPBT Margin | ||||||
Operating Taxes | (1,428) | 3,664 | ||||
Tax Rate | ||||||
NOPAT | (93,509) | (312,923) | ||||
Net income | (1,151,454) -20.89% | (1,455,544) 22.85% | ||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | 1,315 | |||||
BB yield | ||||||
Debt | ||||||
Debt current | 311,039 | 303,947 | ||||
Long-term debt | 88,831 | 25,222 | ||||
Deferred revenue | 242 | |||||
Other long-term liabilities | 22,441 | 31,966 | ||||
Net debt | 306,306 | 105,893 | ||||
Cash flow | ||||||
Cash from operating activities | (2,726,546) | 234,466 | ||||
CAPEX | (2,897) | (27,448) | ||||
Cash from investing activities | 1,119,630 | (429,723) | ||||
Cash from financing activities | 49,906 | 1,066,368 | ||||
FCF | (86,710) | (764,226) | ||||
Balance | ||||||
Cash | 93,564 | 217,875 | ||||
Long term investments | 5,401 | |||||
Excess cash | 35,524 | 185,718 | ||||
Stockholders' equity | (3,298,645) | (2,020,648) | ||||
Invested Capital | 3,443,907 | 3,296,488 | ||||
ROIC | ||||||
ROCE | ||||||
EV | ||||||
Common stock shares outstanding | 7,954 | 7,868 | ||||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | (70,770) | (258,684) | ||||
EV/EBITDA | ||||||
Interest | 38,203 | 12,822 | ||||
Interest/NOPBT |